CJC-1295 + Ipamorelin 10MG

The CJC-1295 + Ipamorelin blend combines two peptides studied for their effects on endocrine signaling pathways. CJC-1295, a GHRH analog, is associated with sustained modulation of somatotroph axis activity and downstream signaling cascades. Ipamorelin, a selective secretagogue-type peptide, has been studied for its selective pituitary signaling activity without significant off-target pathway interference. Together, they may provide complementary activity across multiple endocrine and systemic pathways in experimental settings.

Purpose of Use: Khlay Labs products are exclusively intended for use in laboratory and research settings by qualified professionals. They are not approved for use as pharmaceuticals, agricultural agents, pesticides, food additives, or household items. Mislabeling these products for such purposes is strictly prohibited. All website content is provided for educational purposes only. These products must not, under any circumstances, be administered to humans or animals, as doing so is against the law.

Key Information: Peptides are not classified as dietary supplements. Research chemicals are substances intended solely for medical and scientific study by researchers. These chemicals are strictly for laboratory research purposes and are not approved for human or veterinary use. Labels on research chemicals clearly indicate this distinction, exempting them from certain regulations outlined in Title 21, Parts 100-740 of the Code of Federal Regulations (21CFR).

Disclaimer: Our products are intended exclusively for scientific research and are not designed for human consumption.

FDA Disclaimer: The information and products provided on this website have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.